Arthur L. Burnett II

Study offers practical insights on TRT useAlthough a recent study of testosterone therapy does not fulfill the need for large-scale, randomized, controlled studies of the treatment, “it is very informative in several ways,” writes Arthur L. Burnett, II, MD, MBA.
Study questions use of pre-op cultures to prevent prosthetic infectionIn this video, Dr. Nicholas Kavoussi sits down with Dr. Arthur L. Burnett, II, of the Urology Times Editorial Council to discuss his 2016 AUA presentation, "Preoperative urine cultures for prosthetic urological surgery: What is the evidence?"
Urologist burnout: Exhaustion jumps, satisfaction slumpsA new study suggests physician burnout is increasing among doctors in many specialties, and the statistics for urology are troubling.
What’s on your colleagues’ wish lists for 2016We asked members of our editorial board what they hope to see in the world of urology in the coming year.
AUA Peyronie’s guideline: Dr. Burnett offers highlightsThe recently published AUA practice guideline on Peyronie’s disease provides current clinical principles on diagnosis and treatment of a highly prevalent and clinically significant condition, according to the co-chair of the multidisciplinary panel that developed the guideline.
A curative therapy for ED edges forwardShock wave therapy has now been subjected to multiple randomized, placebo-controlled, and additional open-label studies in clinics worldwide, demonstrating impressive efficacy and safety.
Momentum builds for female sexual dysfunction TxA number of prominent urologists are among the signers of a letter applauding the FDA for holding a workshop on female sexual dysfunction.